1. Livraghi T. Treatment of hepatocellular carcinoma by interventional methods. Eur Radiol. 2001; 11: 2207-2219.

2. Solbiati L, Livraghi T, Goldberg SN, Ierace T, Meloni F, Dellanoce M, Cova L, Gazelle GS. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology. 2001; 221(1): 159-166.

3. Lewin JS, Connell CF, Duerk JL, Spisak J, Gazelle GS, Haaga JR. Interactive MRI-guided radiofrequency interstitial thermal ablation of abdominal tumors: clinical trial for evaluation of safety and feasibility. J Magn Reson Imaging. 1998; 8(1): 40-47.

4. Huppert PE, Trübenbach J, Pereira P, König C, Claussen CD. MRI-guided percutaneous radiofrequency ablation of hepatic neoplasms--first technical and clinical experiences. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr. 2000; 172(8): 692-700.

5. Lencioni R, Cioni D, Bartolozzi C. Percutaneous radiofrequency thermal ablation of liver malignancies: techniques, indications, imaging findings and clinical results. Abdom Imaging. 2001; 26: 345-360.

6. Oudkerk M, Torres CG, König M, Grimm J, Marquardt M, van Dijk P, de Groot J. Characterization of liver lesions with mangafodipir trisodium-enhanced MR imaging : multicenter study comparing MR and dual-phase spiral CT. Radiology. 2002; 223(2): 517-524

7. Schlup S, Becker CD, Terrier F, Mentha G, Roth A. Détection de lésions hépatiques en IRM après injection de MN-DPDP : comparaison à haut (1.5T) et bas (0.23T) champs magnétiques et CT. Swiss Medical Forum Suppl. 2001; 3: 27.